Irreversible electroporation of lung neoplasm: a case series

Mumal Usman, William Moore, Ronak Talati, Kevin Watkins, Thomas V Bilfinger, Mumal Usman, William Moore, Ronak Talati, Kevin Watkins, Thomas V Bilfinger

Abstract

Background: Percutaneous irreversible electroporation (IRE) of lung tumors is a new minimally invasive technique which has recently been used in the treatment of soft tissue tumors.

Case reports: The case histories are presented of two patients with unresectable malignancies in the lung, who underwent irreversible electroporation as a treatment attempt. The procedure was performed under CT guidance and was uneventful.

Conclusions: At follow up 6 months later, the tumors both appeared to have recurred. To our knowledge, no similar cases have previously been reported in the literature.

Figures

Figure 1
Figure 1
33-year-old male with metastatic sarcoma to the right hilum (A), shows one of the three probe inserted and (B) shows the second probe inserted the third probe is not included. (C) Sagittal CT image of the chest in lung window with the overlying treatment planning grid generated by the IRE device showing the three nano-knives within the right hilar metastatic sarcoma.
Figure 2
Figure 2
70-year-old female with biopsy proven lung cancer (A) shows the right para-tracheal location of the mass abutting the posterior wall of the trachea mass with one of three nano-knives in place. (B) Right para-tracheal mass with two of the three nano-knives in place. (C) Probe placement plan-diagram overlying oblique coronal CT image with the three probes within the tumor.

References

    1. Miyamoto T, Baba M, Sugane T, et al. Carbon ion radiotherapy for stage 1 non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol. 2007;2:916–26.
    1. Ghosh S, Sujendran V, Alexiou C, et al. Long term results of surgery versus continuous hyperfractionated accelerated radiotherapy(CHART) in patients aged 70 years with stage 1 non small cell lung cancer. Eur J Cardiothorac Surg. 2003;24:1002–7.
    1. Dupuy DE, Mayo-Smith WW, Abbott GF, et al. Clinical application of radiofrequency tumour ablation in thorax. Radiographics. 2002;22(Special Issue):S259–69.
    1. Steinke K, King J, Glenn D, et al. Radiologic appearance and complications of percutaneous computed tomography – guided radiofrequency – ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr. 2003;27(5):750–57.
    1. Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in non surgical candidates. J ThoracCardiovasc Surg. 2003;12:5929–37.
    1. Mussi A, Ambrogi MC. Percutaneous thermal ablation of lung tumours (editorial) Ann Osp San Camillo Forlanini. 2003:5225–27.
    1. Ambrogi MC, Fontanini G, Lencioni R, et al. A preliminary study on thermal ablation of lung tumour. Contemporary Oncol. 2004:8373–79.
    1. Thomson KR, Cheung W, Ellis SJ, et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol. 2011;22(5):611–21.
    1. Lee EW, Chen C, Prieto VE, et al. Advanced Hepatic Ablation Technique for Creating Complete Cell Death: Irreversible Electroporation. Radiology. 2010;255:426–33.
    1. Zemlyak A, Moore W, Bilfinger T. Comparison of Survival after Sub-lobar Resections and Ablative Therapies for Stage I Non-small Cell Lung Cancer (NSCLC) J Am Coll Surg. 2010;211(1):68–72.
    1. Al-Sakere B, Andre F, Bernat C, et al. Tumor Ablation with Irreversible Electroporation. PLoS ONE. 2007;2(11):e1135.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe